REGULATORY

44 Million Yen Allotted to Fuel Biologics Development: Health Policy Bureau’s FY2019 Budget

December 26, 2018
The FY2019 draft budget of the Ministry of Health, Labor and Welfare’s (MHLW) Health Policy Bureau totals 219,018 million yen, an increase of 25,105 million yen compared to its initial budget for FY2018. This figure includes 44 million yen, 10…

To read the full story

Related Article

REGULATORY

By Shinya Sato

As 2019 rolls in, we expect to see a flurry of approvals in the Japanese regenerative medicine arena, with regulatory decisions anticipated by the end of the year for Novartis Pharma’s CAR-T therapy and many more products, which could bring…

Takeda Pharmaceutical completed the £46 billion acquisition of Shire on January 8, vaulting itself into the top 10 league of…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…